Sector
HealthcareOpen
₹26.77Prev. Close
₹26.5Turnover(Lac.)
₹3.31Day's High
₹27.6Day's Low
₹25.1852 Week's High
₹3552 Week's Low
₹15.68Book Value
₹21.98Face Value
₹10Mkt Cap (₹ Cr.)
11.96P/E
19.3EPS
1.43Divi. Yield
018 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
11 Sep 2023
12:00 AM
AGM
Announcement Date: 11 Sep, 2023
11 Sep 2023
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 4.33 | 4.33 | 4.33 | 4.33 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 4.59 | 6.15 | 5.22 | 4.21 |
Net Worth | 8.92 | 10.48 | 9.55 | 8.54 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 9.77 | 6.1 | 5.26 | 2.78 |
yoy growth (%) | 60.22 | 16.02 | 88.81 | |
Raw materials | -3.6 | -1.14 | -0.6 | -0.62 |
As % of sales | 36.87 | 18.77 | 11.51 | 22.44 |
Employee costs | -0.68 | -0.86 | -0.94 | -0.49 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 1.37 | 0.66 | 0.71 | 0.35 |
Depreciation | -0.51 | -0.42 | -0.34 | -0.13 |
Tax paid | -0.36 | -0.18 | -0.18 | -0.09 |
Working capital | 1.08 | 1.29 | 1.99 | |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 60.22 | 16.02 | 88.81 | |
Op profit growth | 74.85 | 5.87 | 94.57 | |
EBIT growth | 101.4 | -1.11 | 66.42 | |
Net profit growth | 113.25 | -11.11 | 103.32 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,385 | 90.85 | 91,806.5 | 238.8 | 0.09 | 1,894.6 | 536.28 |
Max Healthcare Institute Ltd MAXHEALTH | 920.05 | 130.13 | 89,420.8 | 241.77 | 0.16 | 610.11 | 79.02 |
Fortis Healthcare Ltd FORTIS | 480.8 | 293.17 | 36,298.39 | 68.33 | 0.21 | 307.48 | 120.36 |
Global Health Ltd MEDANTA | 1,202.5 | 89.61 | 32,288.01 | 92.24 | 0 | 578.65 | 106.09 |
Narayana Hrudayalaya Ltd NH | 1,242 | 59.8 | 25,381.61 | 158.09 | 0.32 | 846.31 | 90.04 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Arjan Lalchandani
Whole Time Director & CEO
Mohit Lalchandani
Executive Director & CFO
Anchal Gupta
Independent Director
Rajiv Handa
Independent Director
Prakash Jhuraney
Director
Swati Chandra
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Dr Lalchandani Labs Ltd
Summary
Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories. Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017. The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of Dr. A Lalchandani Pathology Laboratories in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm. The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Dr Lalchandani lab is situated at Greater Kailash, New Delhi State of the art NABL accredited lab in existence since 1986 with fully automatic machines offering world-class diagnostic lab services in New Delhi.The Company is formed to set up, engage, collaborate, acquire, purchase, maintain, open collection centres, conduct, manage, administer, own, run laboratories for the purposes of carrying out pathological investigations of various branches of Bio-Chemistry, He
Read More
What is the Dr Lalchandani Labs Ltd share price today?
The Dr Lalchandani Labs Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹27.6 today.
What is the Market Cap of Dr Lalchandani Labs Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr Lalchandani Labs Ltd is ₹11.96 Cr. as of 19 Jul ‘24
What is the PE and PB ratio of Dr Lalchandani Labs Ltd?
The PE and PB ratios of Dr Lalchandani Labs Ltd is 19.3 and 1.26 as of 19 Jul ‘24
What is the 52 Week High and Low of Dr Lalchandani Labs Ltd?
The 52-week high/low is the highest and lowest price at which a Dr Lalchandani Labs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Dr Lalchandani Labs Ltd is ₹15.68 and ₹35 as of 19 Jul ‘24
What is the CAGR of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd's CAGR for 5 Years at 14.14%, 3 Years at 0.12%, 1 Year at 25.45%, 6 Month at 22.67%, 3 Month at 32.44% and 1 Month at 31.49%.
What is the shareholding pattern of Dr Lalchandani Labs Ltd?
The shareholding pattern of Dr Lalchandani Labs Ltd is as follows:
Promoters - 60.78 %
Institutions - 0.00 %
Public - 39.22 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
